WO2025248535 - NOVEL SPIROCYCLIC COMPOUNDS TO TREAT VIRAL INFECTIONS
National phase entry is expected:
Publication Number
WO/2025/248535
Publication Date
04.12.2025
International Application No.
PCT/IN2024/051915
International Filing Date
30.09.2024
Title **
[English]
NOVEL SPIROCYCLIC COMPOUNDS TO TREAT VIRAL INFECTIONS
[French]
NOUVEAUX COMPOSÉS SPIROCYCLIQUES POUR TRAITER DES INFECTIONS VIRALES
Applicants **
ZYDUS LIFESCIENCES LIMITED
Inventors
DESAI, Ranjit
PANDYA, Vrajesh
Priority Data
202421041764
29.05.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter II
* |
| * | |
| * | |
| * | |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3008 | |
| EPO | Filing, Examination, Granting | 18990 | |
| Japan | Filing, Examination, Granting | 2483 | |
| South Korea | Filing, Examination, Granting | 2672 | |
| USA | Filing, Examination, Granting | 17390 |
Total:
44,543
Abstract[English]
The present invention relates to novel compounds of the formula (I) having potential to treat viral infections especially related to dengue virus, their tautomeric forms, their stereoisomers, their suitable pharmaceutically acceptable salts, their polymorphs, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.[French]
La présente invention concerne de nouveaux composés de formule (I) ayant un potentiel pour traiter des infections virales, en particulier associées au virus de la dengue, leurs formes tautomères, leurs stéréoisomères, leurs sels pharmaceutiquement acceptables appropriés, leurs polymorphes, des compositions pharmaceutiques les contenant, des procédés pour leur préparation, l'utilisation de ces composés en médecine et les intermédiaires impliqués dans leur préparation.